Literature DB >> 21670463

Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer.

Rizwan Haq1, David E Fisher.   

Abstract

Members of the micropthalmia (MiT) family of transcription factors (MITF, TFE3, TFEB, and TFEC) are physiologic regulators of cell growth, differentiation, and survival in several tissue types. Because their dysregulation can lead to melanoma, renal cell carcinoma, and some sarcomas, understanding why these genes are co-opted in carcinogenesis may be of general utility. Here we describe the structure of the MiT family of proteins, the ways in which they are aberrantly activated, and the molecular mechanisms by which they promote oncogenesis. We discuss how meaningful understanding of these mechanisms can be used to elucidate the oncogenic process. Because the expression of these proteins is essential for initiating and maintaining the oncogenic state in some cancer types, we propose ways that they can be exploited to prevent, diagnose, and rationally treat these malignancies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21670463     DOI: 10.1200/JCO.2010.32.6223

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  59 in total

1.  TFEB-mTORC1 feedback loop in metabolism and cancer.

Authors:  Chiara Di Malta; Andrea Ballabio
Journal:  Cell Stress       Date:  2017-10-01

2.  MITF E318K's effect on melanoma risk independent of, but modified by, other risk factors.

Authors:  Marianne Berwick; Jamie MacArthur; Irene Orlow; Peter Kanetsky; Colin B Begg; Li Luo; Anne Reiner; Ajay Sharma; Bruce K Armstrong; Anne Kricker; Anne E Cust; Loraine D Marrett; Stephen B Gruber; Hoda Anton-Culver; Roberto Zanetti; Stefano Rosso; Richard P Gallagher; Terence Dwyer; Alison Venn; Klaus Busam; Lynn From; Kirsten White; Nancy E Thomas
Journal:  Pigment Cell Melanoma Res       Date:  2014-01-30       Impact factor: 4.693

Review 3.  How anti-PD1 treatments are changing the management of melanoma.

Authors:  Peter Hersey; Hojabr Kakavand; James Wilmott; Andre van der Westhuizen; Stuart Gallagher; Kavitha Gowrishankar; Richard Scolyer
Journal:  Melanoma Manag       Date:  2014-12-04

4.  Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.

Authors:  Benoît Marchand; Dominique Arsenault; Alexandre Raymond-Fleury; François-Michel Boisvert; Marie-Josée Boucher
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

5.  Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement.

Authors:  Minghao Zhong; Paul Weisman; Bing Zhu; Maria Brassesco; Youfeng Yang; W Marston Linehan; Maria J Merino; David Zhang; Stephen Rohan; Dongming Cai; Ximing Yang
Journal:  Diagn Mol Pathol       Date:  2013-06

Review 6.  Pro-survival role of MITF in melanoma.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  J Invest Dermatol       Date:  2014-08-21       Impact factor: 8.551

7.  Cooperative antiproliferative signaling by aspirin and indole-3-carbinol targets microphthalmia-associated transcription factor gene expression and promoter activity in human melanoma cells.

Authors:  Kevin M Poindexter; Susanne Matthew; Ida Aronchik; Gary L Firestone
Journal:  Cell Biol Toxicol       Date:  2016-04-07       Impact factor: 6.691

Review 8.  Targeting melanoma by small molecules: challenges ahead.

Authors:  Rizwan Haq; David E Fisher
Journal:  Pigment Cell Melanoma Res       Date:  2013-05-28       Impact factor: 4.693

9.  Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF.

Authors:  Rizwan Haq; Jonathan Shoag; Pedro Andreu-Perez; Satoru Yokoyama; Hannah Edelman; Glenn C Rowe; Dennie T Frederick; Aeron D Hurley; Abhinav Nellore; Andrew L Kung; Jennifer A Wargo; Jun S Song; David E Fisher; Zolt Arany; Hans R Widlund
Journal:  Cancer Cell       Date:  2013-03-07       Impact factor: 31.743

10.  Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein.

Authors:  Rachel Kobos; Makoto Nagai; Masumi Tsuda; Man Yee Merl; Tsuyoshi Saito; Marick Laé; Qianxing Mo; Adam Olshen; Steven Lianoglou; Christina Leslie; Irina Ostrovnaya; Christophe Antczak; Hakim Djaballah; Marc Ladanyi
Journal:  J Pathol       Date:  2013-03-05       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.